Identification of the pathogenic pathways in osteoarthritic hip cartilage: Commonality and discord between hip and knee OA

Osteoarthritis and Cartilage

Volumn 20, Issue 9, 2012, Pages 1029-1038

  Xu, Y ^a   Barter, M J ^a   Swan, D C ^b   Rankin, K S ^a   Rowan, A D ^a   Santibanez Koref, M ^b   Loughlin, J ^a   Young, D A ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Cartilage; Chondrocytes; Gene expression profiling; Microarray; Pathway analysis

Indexed keywords

RNA;

AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FEMUR FRACTURE; GENE EXPRESSION; HIP OSTEOARTHRITIS; HUMAN; HUMAN TISSUE; KNEE OSTEOARTHRITIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION;

AGED; CARTILAGE, ARTICULAR; FEMALE; HUMANS; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TRANSCRIPTOME; WNT SIGNALING PATHWAY;

EID: 84864383496     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2012.05.006     Document Type: Article

References (57)

1. Arden N., Nevitt M.C. Osteoarthritis: epidemiology. Best Pract Res Clin Rheumatol 2006 Feb, 20(1):3-25.
2. Loeser R. Molecular mechanisms of cartilage destruction in osteoarthritis. Biochem J 2008, 8(4):303-306.
3. Brandt K., Radin E., Dieppe P., van de Putte L. Yet more evidence that osteoarthritis is not a cartilage disease. Ann Rheum Dis 2006, 65:1261-1264.
4. Muir H. The chondrocyte, architect of cartilage. Biomechanics, structure, function and molecular biology of cartilage matrix macromolecules. Bioessays 1995 Dec, 17(12):1039-1048.
5. Glasson S.S., Askew R., Sheppard B., Carito B., Blanchet T., Ma H.L., et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 2005 Mar 31, 434(7033):644-648.
6. Jubb R.W., Fell H.B. The breakdown of collagen by chondrocytes. J Pathol 1980 Mar, 130(3):159-167.
7. Karsdal M.A., Madsen S.H., Christiansen C., Henriksen K., Fosang A.J., Sondergaard B.C. Cartilage degradation is fully reversible in the presence of aggrecanase but not matrix metalloproteinase activity. Arthritis Res Ther 2008, 10(3):R63.
8. Davidson R.K., Waters J.G., Kevorkian L., Darrah C., Cooper A., Donell S.T., et al. Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage. Arthritis Res Ther 2006, 8(4):R124.
9. Kevorkian L., Young D.A., Darrah C., Donell S.T., Shepstone L., Porter S., et al. Expression profiling of metalloproteinases and their inhibitors in cartilage. Arthritis Rheum 2004 Jan, 50(1):131-141.
10. Swingler T.E., Waters J.G., Davidson R.K., Pennington C.J., Puente X.S., Darrah C., et al. Degradome expression profiling in human articular cartilage. Arthritis Res Ther 2009, 11(3):R96.
11. Goldring M., Goldring S. Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis. Ann New York Acad Sci 2010, 1192:230-237.
12. Meng J., Ma X., Ma D., Xu C. Microarray analysis of differential gene expression in temporomandibular joint condylar cartilage after experimentally induced osteoarthritis. Osteoarthritis Cartilage 2005, 13(12):1115-1125.
13. Sato T., Konomi K., Yamasaki S., Aratani S., Tsuchimochi K., Yokouchi M., et al. Comparative analysis of gene expression profiles in intact and damaged regions of human osteoarthritic cartilage. Arthritis Rheum 2006, 54(3):808-817.
14. Appleton C., Pitelka V., Henry J., Beier F. Global analyses of gene expression in early experimental osteoarthritis. Arthritis Rheum 2007, 56(6):1854-1868.
15. Dell'accio F., De Bari C., Eltawil N., Vanhummelen P., Pitzalis C. Identification of the molecular response of articular cartilage to injury, by microarray screening: Wnt-16 expression and signaling after injury and in osteoarthritis. Arthritis Rheum 2008, 58(5):1410-1421.
16. Geyer M., Grässel S., Straub R., Schett G., Dinser R., Grifka J., et al. Differential transcriptome analysis of intraarticular lesional vs intact cartilage reveals new candidate genes in osteoarthritis pathophysiology. Osteoarthritis Cartilage 2009, 17(3):328-335.
17. Ijiri K., Zerbini L.F., Peng H., Otu H.H., Tsuchimochi K., Otero M., et al. Differential expression of GADD45beta in normal and osteoarthritic cartilage: potential role in homeostasis of articular chondrocytes. Arthritis Rheum 2008 Jul, 58(7):2075-2087.
18. Aigner T., Fundel K., Saas J., Gebhard P., Haag J., Weiss T., et al. Large-scale gene expression profiling reveals major pathogenetic pathways of cartilage degeneration in osteoarthritis. Arthritis Rheum 2006, 54(11):3533-3544.
19. Scott J.L., Gabrielides C., Davidson R.K., Swingler T.E., Clark I.M., Wallis G.A., et al. Superoxide dismutase downregulation in osteoarthritis progression and end-stage disease. Ann Rheum Dis 2010, 69(8):1502-1510.
20. Karlsson C., Dehne T., Lindahl A., Brittberg M., Pruss A., Sittinger M., et al. Genome-wide expression profiling reveals new candidate genes associated with osteoarthritis. Osteoarthritis Cartilage 2010, 18(4):581-592.
21. O'Connor M.I. Sex differences in osteoarthritis of the hip and knee. J Am Acad Orthop Surg 2007, 15(Suppl 1):S22-S25.
22. Kijowski R., Blankenbaker D., Stanton P., Fine J., De Smet A. Arthroscopic validation of radiographic grading scales of osteoarthritis of the tibiofemoral joint. Am J Roentgenol 2006, 187(3):794-799.
23. Sampson T.G. Arthroscopic treatment for chondral lesions of the hip. Clin Sports Med 2011 Apr, 30(2):331-348.
24. Bolstad B.M., Irizarry R.A., åstrand M., Speed T.P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003, 19(2):185-193.
25. Johnson W.E., Li C., Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 2007 Jan, 8(1):118-127.
26. R Development Core Team R: A Language and Environment for Statistical Computing 2011, Vienna, Austria; [updated 2011; cited]; Available from:. http://www.r-project.org/.
27. Subramanian A., Tamayo P., Mootha V., Mukherjee S., Ebert B., Gillette M., et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005, 102(43):15545-15550.
28. Ashburner M., Ball C., Blake J., Botstein D., Butler H., Cherry M., et al. Gene ontology: tool for the unification of biology. Nat Genet 2000, 25(1):25-29.
29. Szklarczyk D., Franceschini A., Kuhn M., Simonovic M., Roth A., Minguez P., et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 2011, 39(Database issue):D561-D568.
30. Papetti M., Augenlicht L.H. Mybl2, downregulated during colon epithelial cell maturation, is suppressed by miR-365. Am J Physiol Gastrointest Liver Physiol 2011 Sep, 301(3):G508-G518.
31. Zhang Q., Hui W., Litherland G.J., Barter M.J., Davidson R., Darrah C., et al. Differential toll-like receptor-dependent collagenase expression in chondrocytes. Ann Rheum Dis 2008 Nov, 67(11):1633-1641.
32. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc B 1995, 57(1):289-300.
33. Werner T. Bioinformatics applications for pathway analysis of microarray data. Curr Opin Biotechnol 2008 Feb, 19(1):50-54.
34. Velasco J., Zarrabeitia M., Prieto J., Perez-Castrillon J., Perez-Aguilar M., Perez-Nuñez M., et al. Wnt pathway genes in osteoporosis and osteoarthritis: differential expression and genetic association study. Osteoporos Int 2010, 21(1):109-118.
35. Huang J., Xia C., Zheng X., Yi T., Wang X., Song G., et al. 17β-Estradiol promotes cell proliferation in rat osteoarthritis model chondrocytes via PI3K/Akt pathway. Cell Mol Biol Lett 2011, 16(4):564-575.
36. Giatromanolaki A., Sivridis E., Maltezos E., Athanassou N., Papazoglou D., Gatter K., et al. Upregulated hypoxia inducible factor-1alpha and -2alpha pathway in rheumatoid arthritis and osteoarthritis. Arthritis Res Ther 2003, 5(4):R193-R201.
37. Li X., Li J., Cheng K., Lin Q., Wang D., Zhang H., et al. Effect of low-intensity pulsed ultrasound on MMP-13 and MAPKs signaling pathway in rabbit knee osteoarthritis. Cell Biochem Biophys 2011, 61(2):427-434.
38. Giatromanolaki A., Sivridis E., Athanassou N., Zois E., Thorpe P.E., Brekken R.A., et al. The angiogenic pathway 'vascular endothelial growth factor/flk-1(KDR)-receptor' in rheumatoid arthritis and osteoarthritis. J Pathol 2001, 194(1):101-108.
39. Yudoh K., Nguyen T., Nakamura H., Hongo-Masuko K., Kato T., Nishioka K. Potential involvement of oxidative stress in cartilage senescence and development of osteoarthritis: oxidative stress induces chondrocyte telomere instability and downregulation of chondrocyte function. Arthritis Res Ther 2005, 7(2):R380-R391.
40. Litherland G.J., Dixon C., Lakey R.L., Robson T., Jones D., Young D.A., et al. Synergistic collagenase expression and cartilage collagenolysis are phosphatidylinositol 3-kinase/Akt signaling-dependent. J Biol Chem 2008 May 23, 283(21):14221-14229.
41. Onishi R.M., Gaffen S.L. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology 2010 Mar, 129(3):311-321.
42. Lisignoli G., Manferdini C., Codeluppi K., Piacentini A., Grassi F., Cattini L., et al. CCL20/CCR6 chemokine/receptor expression in bone tissue from osteoarthritis and rheumatoid arthritis patients: different response of osteoblasts in the two groups. J Cell Physiol 2009 Oct, 221(1):154-160.
43. Hirota K., Yoshitomi H., Hashimoto M., Maeda S., Teradaira S., Sugimoto N., et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med 2007 Nov 26, 204(12):2803-2812.
44. Prasadam I., van Gennip S., Friis T., Shi W., Crawford R., Xiao Y. ERK-1/2 and p38 in the regulation of hypertrophic changes of normal articular cartilage chondrocytes induced by osteoarthritic subchondral osteoblasts. Arthritis Rheum 2010 May, 62(5):1349-1360.
45. Yatsugi N., Tsukazaki T., Osaki M., Koji T., Yamashita S., Shindo H. Apoptosis of articular chondrocytes in rheumatoid arthritis and osteoarthritis: correlation of apoptosis with degree of cartilage destruction and expression of apoptosis-related proteins of p53 and c-myc. J Orthop Sci 2000, 5(2):150-156.
46. Hai T., Wolford C.C., Chang Y.S. ATF3, a hub of the cellular adaptive-response network, in the pathogenesis of diseases: is modulation of inflammation a unifying component?. Gene Expr 2010, 15(1):1-11.
47. Loeser R.F., Shanker G., Carlson C.S., Gardin J.F., Shelton B.J., Sonntag W.E. Reduction in the chondrocyte response to insulin-like growth factor 1 in aging and osteoarthritis: studies in a non-human primate model of naturally occurring disease. Arthritis Rheum 2000 Sep, 43(9):2110-2120.
48. Ivanavicius S.P., Ball A.D., Heapy C.G., Westwood F.R., Murray F., Read S.J. Structural pathology in a rodent model of osteoarthritis is associated with neuropathic pain: increased expression of ATF-3 and pharmacological characterisation. Pain 2007 Apr, 128(3):272-282.
49. Dell'accio F., Vincent T.L. Joint surface defects: clinical course and cellular response in spontaneous and experimental lesions. Eur Cell Mater 2010, 20:210-217.
50. Miklos G.L., Maleszka R. Microarray reality checks in the context of a complex disease. Nat Biotechnol 2004 May, 22(5):615-621.
51. Rowan A.D., Young D.A. Collagenase gene regulation by pro-inflammatory cytokines in cartilage. Front Biosci 2007, 12:536-550.
52. Klesney-Tait J., Turnbull I.R., Colonna M. The TREM receptor family and signal integration. Nat Immunol 2006 Dec, 7(12):1266-1273.
53. Kuai J., Gregory B., Hill A., Pittman D.D., Feldman J.L., Brown T., et al. TREM-1 expression is increased in the synovium of rheumatoid arthritis patients and induces the expression of pro-inflammatory cytokines. Rheumatology (Oxford) 2009 Nov, 48(11):1352-1358.
54. Kim T.H., Choi S.J., Lee Y.H., Song G.G., Ji J.D. Soluble triggering receptor expressed on myeloid cells-1 as a new therapeutic molecule in rheumatoid arthritis. Med Hypotheses 2012 Feb, 78(2):270-272.
55. Denko C.W., Malemud C.J. Role of the growth hormone/insulin-like growth factor-1 paracrine axis in rheumatic diseases. Semin Arthritis Rheum 2005 Aug, 35(1):24-34.
56. Kwan Tat S., Pelletier J.P., Amiable N., Boileau C., Lavigne M., Martel-Pelletier J. Treatment with ephrin B2 positively impacts the abnormal metabolism of human osteoarthritic chondrocytes. Arthritis Res Ther 2009, 11(4):R119.
57. Rowan A.D., Litherland G.J., Hui W., Milner J.M. Metalloproteases as potential therapeutic targets in arthritis treatment. Expert Opin Ther Targets 2008 Jan, 12(1):1-18.